---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-027829"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2026-08-14T12:01:16+00:00"
generated_at: "2026-08-14T12:05:31.358531+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BIO-key Q2 revenue up 13% to $1.9M, net loss narrows 51% to $577K; raises $2.5M

## Summary
- Q2 revenue $1.92M, up 13% YoY; license fee revenue up 53% to $1.23M.
- Net loss improved to $(577K) or $(0.56)/share vs $(1.17M) or $(2.01)/share in Q2'25; gross margin 87% vs 73%.
- Raised $2.5M via warrant exercise at $4.06/share; cash now over $4.5M; reduced 2025 note by $350K to $325K.
- 1H'26 revenue up 23%, net loss improved 59%; targets profitability in 2H'26.
- New wins: Saudi Arabia education, Portugal national security, Central Bank of Jordan, Alabama credit union; completed 1-for-10 reverse split.

## SEC filing metadata
- accession: 0001437749-26-027829
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2026-08-14T12:01:16+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774926027829/0001437749-26-027829-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774926027829/bkyi20260813c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-027829
- JSON: https://secwatch.observer/filing/0001437749-26-027829.json
- Plain text: https://secwatch.observer/filing/0001437749-26-027829.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.